Effects of Insulin on Blood Flow and Volume in Skeletal Muscle of Patients With IDDM: Studies Using [15O]H2O, [15O]CO, and Positron Emission Tomography
- Maria Raitakari,
- Pirjo Nuutila,
- Juhani Knuuti,
- Olli T Raitakari,
- Hanna Laine,
- Ulla Ruotsalainen,
- Olli Kirvelä,
- Teemu O Takala,
- Hidehiro Iida and
- Hannele Yki-Järvinen
- Turku Positron Emission Tomography Center Turku, Finland
- Departments of Anesthesiology, Clinical Chemistry Turku, Finland
- Clinical Physiology Turku, Finland
- Medicine Turku, Finland
- University of Turku Turku, Finland
- Research Center for Brain and Blood Vessels Akita, Japan
- Department of Medicine, University of Helsinki Helsinki, Finland
- Address correspondence and reprint requests to Dr. Pirjo Nuutila, Dept. of Medicine, University of Turku, Kiinamyllynkatu 4-6, FIN-20520 Turku, Finland.
Exaggerated vasoconstriction and blunted vasodilation of peripheral resistance arteries to various vasoactive agents characterize patients with IDDM. We characterized the hemodynamic effects of insulin in skeletal muscle in patients with IDDM. Muscle blood flow and blood volume were measured basally and during a highdose insulin infusion (5 mU · kg−1 · min−1) in seven normotensive patients with IDDM (age, 30 ± 6 years; BMI, 24.5 ± 2.0 kg/m2; blood pressure, 124 ± 12/78 ± 11 mmHg) and nine matched normal subjects, using [15O]H2O, [15O]CO, and positron emission tomography (PET). Whole-body insulin sensitivity was determined using the euglycemic insulin clamp technique. Insulinstimulated whole-body glucose uptake was significantly lower in the patients with IDDM (45 ± 15 μmol · kg−1 · min−1) than in the normal subjects (62 ± 14 umol · kg−1 · min−1) (P < 0.05). Insulin increased muscle blood flow by 111 ± 69% above basal from 3.0 ± 2.0 to 5.8 ± 3.0 ml · 100 g−1 muscle · min−1 (P < 0.005) in the normal subjects, but only by 42 ± 30% from 2.0 ± 0.9 to 2.9 ± 1.4 ml · 100 g−1 muscle · min−1 (P < 0.005) in patients with IDDM (P < 0.05 for change in flow in IDDM vs. normal subjects). The calculated muscle vascular resistances were comparable basally, but higher during hyperinsulinemia in the patients with IDDM (37 ± 17 mmHg · 100 g · min · ml−1) than in the normal subjects (16 ± 7 mmHg · 100 g · min · ml−1) (P < 0.05). Muscle blood volume increased significantly by insulin in both groups without any difference between the groups. We conclude that the ability of supraphysiological concentrations of insulin to stimulate muscle blood flow is blunted in patients with IDDM, because of the inability of insulin to stimulate linear flow velocity rather than blood volume in skeletal muscle. This defect adds yet another defect to the list of abnormalities in vascular function in IDDM, which might predispose these patients to develop hypertension.
- Received February 21, 1997.
- Revision received June 16, 1997.
- Accepted June 16, 1997.
- Copyright © 1997 by the American Diabetes Association